08/03/2011

Other UK News In Brief

Royal Couple In NI

Prince William and his wife-to-be, Kate Middleton have arrived in Northern Ireland for a one-day visit. The couple arrived at Belfast City Hall at about 10.30am and were met by Lord Mayor Pat Convery and Dame Mary Peters, a former Olympic pentathlon athletics champion who is now the Lord Lieutenant of Belfast in the first in a series of engagements planned for them. It is Prince William's first royal visit to Northern Ireland and comes in the run-up to the couple's preparations for the Royal Wedding on 29 April. Last week, it was announced that the Queen would visit the Republic of Ireland later this year.

A Winter Of Contrasts

This winter wasn't as cold as last year, despite the exceptionally cold December, Met Office provisional figures show. The mean UK temperature was 2.4 °C, compared to 1.6 °C last winter. A 'normal' winter average temperature would be 3.7 °C. Heavy snow and very cold weather dominated the UK through much of December, however, during January UK mean temperatures were close to average and by February were above average. Through the course of the winter, the UK went from the coldest December on record to the ninth warmest February on record. Met Office forecasts and warnings highlighted the severe weather throughout the coldest December in the UK for at least 100 years.

David Willetts Addresses Office For Fair Access Guidance To Universities

Commenting on the Office for Fair Access Guidance to Universities published this week, Minister for Universities and Science David Willetts said: “Universities are being asked to work much harder to recruit students from disadvantaged backgrounds in the future. The Director has moved quickly to give universities clarity about what he expects from them on access. The Government has been clear that universities charging more than £6,000 who are not meeting their access benchmarks should redouble their efforts to widen participation. There is a range of good practice across the sector to draw on, as well as the new National Scholarship Programme which the Government is match funding.”

High Levels Of 'Good' Cholesterol May Cut Bowel Cancer Risk




High levels of “good” (high density lipoprotein) HDL cholesterol seem to cut the risk of bowel cancer, suggests research published online in Gut. 

The association is independent of other potentially cancer-inducing markers of inflammation in the blood. 

The researchers base their findings on participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. This is tracking the long term impact of diet on the development of cancer in more than half a million people in 10 European countries, including the UK. 

Some 1,200 people who developed bowel and rectal cancers, 779 bowel and 459 rectal cancer, after agreeing to take part in EPIC were matched with another 1,200 participants of the same age, gender, and nationality.

 Blood samples taken when they joined the study, and the dietary questionnaires these participants had completed, were compared to see if there were any discernible differences between the two groups. 

The analysis showed that those who had the highest levels of HDL cholesterol, and another blood fat, apolipoprotein A, or apoA, a component of HDL cholesterol, had the lowest risk of developing bowel cancer. 

Each rise of 16.6 mg/dl in HDL and of 32 mg/dl in apoA reduced the risk of bowel cancer by 22% and 18%, respectively, after taking account of diet, lifestyle, and weight. 

But HDL and apoA levels had no impact on the risk of rectal cancer. 

After excluding those who had only been monitored for two years, as they may have already been undergoing cancerous changes when they joined the study, only levels of HDL were associated with a reduction in bowel cancer risk. 

The association remained intact, irrespective of other indicators of inflammation, insulin resistance, and oxygen free radicals levels, all of which are associated with the development of cancer. 

The authors explain that low HDL levels have been linked to higher levels of proteins involved in inflammation, while higher levels of proteins that dampen down the inflammatory response have also been linked to high HDL levels. 

The pro inflammatory proteins boost cell growth and proliferation while curbing cell death, so HDL may alter the inflammatory process in some way, they suggest.

(BMcN)/KMcA)

Related UK National News Stories
Click here for the latest headlines.

25 March 2014
Cancer Research UK Raises Over £8m In Six Days
Cancer Research UK has raised over £8 million in donations in just six days thanks to the #nomakeupselfie trend. The #nomakeupselfie trend isn't something Cancer Research UK started.
08 August 2011
Cancer Survivors 'Should Exercise', Charity Claims
More than a million cancer survivors could be putting themselves at risk of long-term health problems because they are not physically active enough, a report by Macmillan Cancer Support has claimed. The charity's report, Move More, said that of the two million cancer survivors in the UK, around 1.
17 October 2005
Breast cancer can cost ‘thousands’
Breast cancer can cost sufferers thousands of pounds, a survey by a leading cancer charity has revealed. Macmillan Cancer Relief surveyed 50 cancer patients and found that, on average, they spent almost £2,000 on extra costs during their treatment.
05 December 2006
Obesity 'could increase number of cancer cases'
Rising obesity levels could lead to up to 12,000 new cases of cancer being diagnosed in the UK by the year 2010, a leading cancer charity has warned. Cancer Research UK warned that if obesity levels continued to rise, then the number of cancer cases linked to excess weight, including breast, womb, kidney and bowel cancer, would increase. Around 24.
30 August 2005
Cancer services spending reaches record levels
The amount of spending on cancer services has reached record levels, the government has announced. According to the latest figures, additional investment in cancer services has reached £639 million, since 2000/01 - £69 million more than was committed in the 2000 NHS Cancer Plan.